FRM
ICPT
Fox Run Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-26,673
| Closed | -$358K | – | 1036 |
|
|
2023
Q1 | $358K | Buy |
+26,673
| New | +$358K | 0.12% | 351 |
|
|
2022
Q3 | – | Sell |
-11,216
| Closed | -$155K | – | 880 |
|
|
2022
Q2 | $155K | Buy |
+11,216
| New | +$155K | 0.08% | 439 |
|
|
2019
Q3 | – | Sell |
-4,099
| Closed | -$326K | – | 608 |
|
|
2019
Q2 | $326K | Buy |
+4,099
| New | +$326K | 0.22% | 195 |
|
|
2018
Q1 | – | Sell |
-19,786
| Closed | -$1.16M | – | 982 |
|
|
2017
Q4 | $1.16M | Buy |
19,786
+10,886
| +122% | +$636K | 0.34% | 43 |
|
|
2017
Q3 | $517K | Buy |
8,900
+2,900
| +48% | +$168K | 0.15% | 286 |
|
|
2017
Q2 | $726K | Buy |
6,000
+2,100
| +54% | +$254K | 0.25% | 108 |
|
|
2017
Q1 | $441K | Buy |
+3,900
| New | +$441K | 0.18% | 227 |
|